Search

Your search keyword '"Guida, G. E."' showing total 7 results
Start Over Author "Guida, G. E."
7 results on '"Guida, G. E."'

1. Proteinuria and blood pressure as causal components of progression to end-stage renal failure

Author

Locatelli, F., Marcelli, D., Comelli, M., Alberti, D., Graziani, G., Buccianti, G., Redaelli, B., Giangrande, A., Marai, P., Tentori, F., Ponti, R., Ambroso, G., Aroldi, A., Ponticelli, C., Gentile, M. G., Manna, M. G., D'Amico, G., Cresseri, D., Lorenz, M., Vigano, M. R., Bonoldi, G., Castighoni, A., Donati, D., Gastaldi, L., Como, G., Silenzio, R., Brancaccio, D., Gotti, E., Mecca, G., Dozio, B., Cairo, G., Conte, F., Meroni, M., Sessa, A., Picardi, L., Villa, G., Salvadeo, A., Cosci, P., Surian, M., Depetri, C., Mileti, M., Bracchi, O., Giraldi, B., Grassi, C., Reina, E., Malcangi, U., Ramello, A., Baruffaldi, M., Baroni, C., Guida, G. E., Verzetti, G., Costantino, A., Vallino, F., Bassi, S., Poiatti, P., Castellani, A., Gaiani, G., Lusvarghi, E., Francucci, B. M., and Battiros, G.

Subjects
Proteinuria, Multicentre, End-stage renal failure, Blood pressure, Hypertension, Prognostic factors, Prospective randomized trial
Published
1996

2. [Hemodialysis equipment].

Author

Navino C, Barbé MC, Ruva CE, Guida GE, De Leo M, Cusaro C, Pecora S, Chiarinotti D, Zamboni G, and Verzetti G

Subjects
Hemodialysis Solutions, Hemodialysis, Home instrumentation, Humans, Monitoring, Physiologic instrumentation, Renal Dialysis instrumentation
Published
1994

3. [The lipid model in hemodialyzed patients].

Author

Navino C, Zamboni G, Barbè MC, Guida GE, Ruva CE, De Leo M, Cusaro C, Pecora S, Chiarinotti D, and Verzetti G

Subjects
Adult, Aged, Arteriosclerosis etiology, Cardiovascular Diseases etiology, Cardiovascular Diseases prevention & control, Female, Humans, Hyperlipidemias drug therapy, Hyperlipidemias epidemiology, Hyperlipidemias physiopathology, Incidence, Lipolysis, Lipoproteins blood, Lovastatin analogs & derivatives, Lovastatin therapeutic use, Male, Middle Aged, Risk Factors, Simvastatin, Smoking, Uremia complications, Uremia therapy, Hyperlipidemias etiology, Renal Dialysis
Abstract

In the context of metabolic alteration in dialysis patients the Authors have studied the characteristics, incidence, pathogenesis, effect of dialysis, atherogenic risk and therapeutic approach to hyperlipemia in hemodialysis patients. Hypertriglyceridemia secondary to reduced lipolytic activity is the most frequent alteration observed in hemodialytic patients (36.7% of cases). In addition, hemodialysis reduces the levels of lipoprotein in the blood whereas the atherogenic role of hyperlipemia does not appear to be as important as that of arterial hypertension and smoking. Simvastatin breaks down the lipidic fractions which are involved in atherogenesis and coronary cardiopathy, thus acting as a valuable prevention against cardiovascular involvement in dialysis.

Published
1991

4. [The intradialytic kinetics of uremic toxins in the diffusion-convection hemodialysis method].

Author

Navino C, Barbè MC, Chiarinotti D, Guida GE, Cusaro C, Fortina A, De Leo M, Pecora S, and Verzetti G

Subjects
Creatinine analysis, Hemodialysis Solutions, Hemofiltration, Humans, Kinetics, Phosphates analysis, Urea analysis, Uremia therapy, beta 2-Microglobulin analysis, Renal Dialysis methods, Uremia metabolism
Abstract

A kinetic evaluation of dialytic methods using a diffusive-convective mechanism in comparison to the standard bicarbonate dialysis was performed in order to verify the possible therapeutic uses. The "kinetic" comparison of PFD and HDF to HBD, using equal quantities of dialysate, showed no significant change in the mention of uremic toxins of small molecular weight and a more efficient capacity to extract beta 2M by the diffusive-convective methods. The biophysical evaluation of dialysis still appears to represent the best means of defining the clearance possibilities and of identifying the most suitable technique for achieving a dialytic adequacy.

Published
1990

6. [Antihypertensive drugs and the kidney].

Author

Verzetti G, Guida GE, Navino C, Chiarinotti D, Ragazzoni E, Barbè MC, Cusaro C, De Leo M, Pecora S, and Peona C

Subjects
Adrenergic beta-Antagonists adverse effects, Adrenergic beta-Antagonists pharmacology, Angiotensin-Converting Enzyme Inhibitors adverse effects, Angiotensin-Converting Enzyme Inhibitors pharmacology, Antihypertensive Agents adverse effects, Calcium Channel Blockers adverse effects, Calcium Channel Blockers pharmacology, Humans, Kidney Diseases chemically induced, Kidney Diseases complications, Antihypertensive Agents pharmacology, Kidney drug effects
Published
1988

7. [Separate and combined effects of an ACE-inhibitor and low-protein low-phosphorus diet in chronic proteinuric glomerular nephropathies].

Author

Cusaro C, Barbè MC, Chiarinotti D, Ragazzoni E, De Leo M, Guida GE, Navino C, Pecora S, Peona C, and Verzetti G

Subjects
Adult, Amino Acids, Essential administration & dosage, Chronic Disease, Combined Modality Therapy, Enalapril therapeutic use, Female, Glomerulonephritis, Membranoproliferative diet therapy, Glomerulonephritis, Membranoproliferative drug therapy, Glomerulonephritis, Membranous diet therapy, Glomerulonephritis, Membranous drug therapy, Humans, Male, Middle Aged, Proteinuria prevention & control, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Dietary Proteins administration & dosage, Glomerulonephritis, Membranoproliferative therapy, Glomerulonephritis, Membranous therapy, Phosphorus administration & dosage
Published
1988

Catalog

Books, media, physical & digital resources
See catalog results